xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
Usd: 185 Special Discount
Specification
Catalog# HA600098
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
Mouse
-
unconjugated
Safety datasheet
Overview
Product Name
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
293 cell line overexpressing SLC7A11.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, IHC-P, FC
Molecular Weight
Predicted band size: 55 kDa
Positive Control
HT-29 cell lysates, HeLa, A549, HT-29, human colon tissue, human pancreas tissue.
Conjugation
unconjugated
Clone Number
A7C6
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000
-
IF-Cell
-
1:100-1:250
-
IHC-P
-
1:200-1:600
-
FC
-
1:1,000
Target
Function
This gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death.
Background References
1. Koppula P. et. al. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021 Aug
2. Lin W. et. al. SLC7A11/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020 Oct
Subcellular Location
Cell membrane, Cell projection, microvillus membrane.
Synonyms
Amino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
ExpandAmino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
solute carrier family 7 antibody
Solute carrier family 7 member 11 antibody
Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 antibody
SYSTEM Xc(-) TRANSPORTER-RELATED PROTEIN antibody
xCT antibody
XCT_HUMAN antibody
CollapseImages
-
Western blot analysis of xCT / SLC7A11 on HT-29 cell lysates with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/1,000 dilution.
Lysates/proteins at 10 µg/Lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Exposure time: 2 minute 30 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA600098) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of A549 cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of HT-29 cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HT-29 cells labeling xCT / SLC7A11.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA600098, 1/1,000) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for 30 minutes, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Immunohistochemical analysis of paraffin-embedded human colon tissue with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/600 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA600098) at 1/600 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human pancreas tissue with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA600098) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Giving Old Drugs New Life: Disulfiram Alleviates Microglial Pyroptosis and Disulfidptosis-like Cytoskeletal/Mitochondrial Alterations in Cerebral Ischemia-reperfusion Injury
Journal: Brain Research Bulletin
DOI: 10.1016/j.brainresbull.2026.111845
IF: 3.7
Application: WB,IF-tissue
Reactivity: Rat
Publish date: 2026 Mar
-
Ginsenoside Rg1 attenuates PM2.5-induced neurotoxicity by suppressing ferroptosis via the Nrf2/GPx4 axis
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2026.121464
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Ultrasound and ROS-responsive nanodroplets inhibit TCA cycle in hepatocellular carcinoma
Journal: Journal Of Nanobiotechnology
DOI: 10.1186/s12951-026-04190-y
IF: 12.6
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 Mar
-
Manganese Biomineralized Ferritin Nanoplatforms with Shielding and Stimuli-Responsive Release for Potentiated Ferroptosis and Multimodal Ovarian Cancer Therapy
Journal: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S548411
IF: 6.5
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Jan
-
NOX2 exacerbates periodontitis via JAK2-STAT3-mediated ferroptosis of gingival epithelial cells
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2026.1744612
IF: 5.9
Application: WB
Reactivity: Human,Mouse
Publish date: 2026 Feb
-
Synergistic ferroptosis-immunotherapy nanoassembly via PROTAC-mediated SLC7A11 degradation and trisulfide-driven glutathione depletion for enhanced antitumor efficacy
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2025.168827
IF: 13.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Licochalcone B targets neural cell adhesion molecule 1 to inhibit osteosarcoma progression and ferroptosis resistance via extracellular signal-regulated kinase 5 and nuclear factor kappa B pathways
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.157584
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
Journal: Frontiers In Oncology
DOI: 10.3389/fonc.2025.1580828
IF: 3.5
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 May
-
Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.116978
IF: 5.3
Application: WB/IF -Tissue
Reactivity: Rat
Publish date: 2025 May
-
Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
Journal: Drug Design Development And Therapy
DOI: 10.2147/DDDT.S509357
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Inhalation exposure to cationic nanoplastic induces ferroptosis in the lung by perturbing core circadian transcription factors Bmal1
Journal: Journal Of Hazardous Materials
DOI: 10.1016/j.jhazmat.2025.139048
IF: 11.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
5‐HT7R Deficiency Alleviates ADP‐Heptose‐Induced Cognitive Impairment via Inhibiting Ferroptosis and Neuroinflammation in Mice
Journal: CNS Neuroscience & Therapeutics
DOI: 10.1111/cns.70455
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
Synergizing Ferroptosis and Immunotherapy via a PROTAC/PDT/HPK1 Inhibitor-Loaded Nanoplatform for Enhanced Antitumor Efficacy
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202507906
IF: 19
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer
Journal: Breast Cancer Research
DOI: 10.1186/s13058-025-02078-7
IF: 5.6
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jul
-
3-hydroxyanthranilic acid analog mitigates ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis through the activation of Nrf2/HO-1/GPX4
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115117
IF: 4.7
Application: WB
Reactivity: Rat
Publish date: 2025 Jul
-
WTX-L/β-arrestin2/LCN2 axis controls vulnerability to ferroptosis in gastric cancer
Journal: iScience
DOI: 10.1016/j.isci.2025.111964
IF: 4.6
Application: IF-cell
Reactivity: Human
Publish date: 2025 Feb
-
Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.117628
IF: 5.6
Application: WB
Reactivity: Human
Publish date: 2025 Dec
-
F-box/WD Repeat-Containing Protein 5 Promotes Breast Cancer Progression by Regulating Ferroptosis via Enhancing Krüppel-like Factor 13 Ubiquitination Through Phosphoinositide 3-Kinase/Serine/Threonine Protein Kinase Pathway
Journal: Rejuvenation Research
DOI: 10.1089/rej.2024.0111
IF: 2.2
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Constitutive hepatic mTORC1 activation aggravates alcohol-induced liver injury via endoplasmic reticulum stress-mediated ferroptosis
Journal: American Journal Of Pathology
DOI: 10.1016/j.ajpath.2025.03.005
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
Bioactive Nanoliposomes for Enhanced Sonodynamic-Triggered Disulfidptosis-Like Cancer Cell Death via Lipid Peroxidation
Journal: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S464178
IF: 6.6
Application: IF-cell
Reactivity: Mouse
Publish date: 2024 Sept
-
QBT improved cognitive dysfunction in rats with vascular dementia by regulating the Nrf2/xCT/GPX4 and NLRP3/Caspase-1/GSDMD pathways to inhibit ferroptosis and pyroptosis of neurons
Journal: International Immunopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Rat
Publish date: 2024 Sep
-
Polystyrene nanoplastic exposure actives ferroptosis by oxidative stress-induced lipid peroxidation in porcine oocytes during maturation
Journal: Journal Of Animal Science And Biotechnology
DOI:
IF: 6.3
Application: WB
Reactivity: Pig
Publish date: 2024 Sep
-
Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1α/HO-1 axis
Journal: Phytomedicine
DOI:
IF: 6.7
Application: IHC-P
Reactivity: Mouse
Publish date: 2024 Oct
-
The SIRT6/BAP1/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI
Journal: Cellular Signalling
DOI:
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
NPR1 promotes cisplatin resistance by inhibiting PARL-mediated mitophagy-dependent ferroptosis in gastric cancer
Journal: Cell Biology And Toxicology
DOI:
IF: 5.3
Application: WB
Reactivity: Mouse
Publish date: 2024 Nov
-
Sensing of mitochondrial DNA by ZBP1 promotes RIPK3- mediated necroptosis and ferroptosis in response to diquat poisoning
Journal: Cell Death & Differentiation
DOI:
IF: 13.7
Application: WB
Reactivity: Mouse
Publish date: 2024 May
-
Nicotine promotes Staphylococcus aureus-induced osteomyelitis by activating the Nrf2/Slc7a11 signaling axis
Journal: International Immunopharmacology
DOI:
IF: 5.6
Application: IHC-P
Reactivity: Mouse
Publish date: 2024 May
-
Saikosaponin A attenuates osteoclastogenesis and bone loss by inducing ferroptosis
Journal: Frontiers In Molecular Biosciences
DOI: 10.3389/fmolb.2024.1390257
IF: 3.9
Application: WB
Reactivity: Mouse
Publish date: 2024 Jul
-
Site 1 protease aggravates acute kidney injury by promoting tubular epithelial cell ferroptosis through SIRT3-SOD2-mtROS signaling
Journal: FEBS Journal
DOI: 10.1111/febs.17057
IF: 5.5
Application: WB
Reactivity: Mouse
Publish date: 2024 Jan
-
Tomatidine Alleviates Intervertebral Disc Degeneration by Activating the Nrf2/HO-1/GPX4 Signaling Pathway
Journal: Drug Design Development And Therapy
DOI:
IF: 4.7
Application: WB
Reactivity: Rat
Publish date: 2024 Dec
-
MAPK Signaling-Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin-Induced Apoptosis and Ferroptosis
Journal: Advanced Science
DOI:
IF: 14.3
Application: IHC-P
Reactivity: Human
Publish date: 2024 Aug
-
Multimodal enhancement of ferroptosis for synergistic cascade colorectal cancer therapy
Journal: Chemical Engineering Journal
DOI:
IF: 13.3
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
FBXW7-Mediated Downregulation of GPX4 Aggravates Acute Kidney Injury Following Ischemia‒Reperfusion
Journal: Inflammation
DOI: 10.1007/s10753-024-02137-9
IF: 4.5
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11
Journal: Archives Of Oral Biology
DOI: 10.1016/j.archoralbio.2023.105807
IF: 3
Application: IHC-P
Reactivity: Human
Publish date: 2023 Sept
-
YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones
Journal: Biomedicines
DOI:
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2023 Oct
-
Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3
Journal: Journal Of Clinical Periodontology
DOI:
IF: 6.7
Application: IHC-P
Reactivity: Mouse
Publish date: 2023 Nov
-
Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer
Journal: International Journal Of Biological Sciences
DOI:
IF: 10.750
Application: WB
Reactivity: Mouse
Publish date: 2023 May
-
p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 7.5
Application: WB
Reactivity: Mouse
Publish date: 2023 Aug
-
H1N1 influenza virus infection through NRF2-KEAP1-GCLC pathway induces ferroptosis in nasal mucosal epithelial cells
Journal: Free Radical Biology And Medicine
DOI:
IF: 7.4
Application: WB
Reactivity: Mouse
Publish date: 2023 Aug
Products with the same target and pathway
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [PSH19-94]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [PSH19-94] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C5]
Application: WB,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [JE31-93]
Application: WB,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated